Global Wearable Healthcare Devices Market 2022-2032

1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Fact.MR Analysis and Recommendations

2.1. Market Coverage/Taxonomy
2.2. Market Definition/Scope/Limitations

3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Wearable Healthcare Devices Demand
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Mn)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends

4.1. Wearable Healthcare Devices Market, by Key Countries
4.2. Wearable Healthcare Devices Market Opportunity Assessment (US$ Mn)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Growth in Automation, By Country
4.5.3. Wearable Healthcare Devices Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Wearable Healthcare Devices Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking

6.1. Historical Market Analysis, 2015-2021
6.2. Current and Future Market Projections, 2022-2032
6.3. Y-o-Y Growth Trend Analysis

7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis

8.1. Introduction/Key Findings
8.2. Historical Market Value (US$ Mn) and Analysis By Product, 2015-2021
8.3. Current and Future Market Value (US$ Mn) and Analysis and Forecast By Product, 2022-2032
8.3.1. Trackers
8.3.2. Smartwatches
8.3.3. Pathes
8.3.4. Smart Clothing
8.4. Market Attractiveness Analysis By Product

9.1. Introduction/Key Findings
9.2. Historical Market Value (US$ Mn) and Analysis By Application, 2015-2021
9.3. Current and Future Market Value (US$ Mn) and Analysis and Forecast By Application, 2022-2032
9.3.1. General Health and Fitness
9.3.2. Remote Patient Monitoring
9.3.3. Home Healthcare
9.4. Market Attractiveness Analysis By Application

10.1. Introduction/Key Findings
10.2. Historical Market Value (US$ Mn) and AnalysisBy Device Type, 2015-2021
10.3. Current and Future Market Value (US$ Mn) and Analysis and ForecastBy Device Type, 2022-2032
10.3.1. Diagnostic and Monitoring Devices
10.3.1.1. Vital Sign Monitoring Devices
10.3.2. Vital Sign Monitoring Devices
10.3.3. ECG\Heart Rate Monitors
10.3.4. Blood Pressure Monitors
10.3.4.1. Pulse Oximeters
10.3.4.2. Glucose Monitoring Devices
10.3.5. Wrist Actigraphs
10.3.6. Polysomnography Devices
10.3.6.1. Sleep Monitoring Devices
10.3.6.2. Fetal monitoring and Obstetric Devices
10.3.6.3. Neuromonitoring Devices
10.3.6.4. Other Diagnostic and Monitoring Devices
10.3.7. Traditional Diagnostic Tests
10.3.7.1. Pain Management Devices
10.3.7.2. Rehabilitation Devices
10.3.7.3. Respiratory Therapy Devices
10.3.7.4. Insulin Pumps
10.4. Market Attractiveness AnalysisBy Device Type

11.1. Introduction/Key Findings
11.2. Historical Market Value (US$ Mn) and Analysis By Grade Type, 2015-2021
11.3. Current and Future Market Value (US$ Mn) and Analysis and Forecast By Grade Type, 2022-2032
11.3.1. Consumer-Grade Wearable Healthcare Devices
11.3.2. Clinical-Grade Wearable Healthcare Devices
11.4. Market Attractiveness Analysis By Grade Type

12.1. Introduction/Key Findings
12.2. Historical Market Value (US$ Mn) and Analysis By Distribution Channel, 2015-2021
12.3. Current and Future Market Value (US$ Mn) and Analysis and Forecast By Distribution Channel, 2022-2032
12.3.1. Pharmacies
12.3.2. Online Channel
12.3.3. Hypermarkets
12.4. Market Attractiveness Analysis By Distribution Channel

13.1. Introduction
13.2. Historical Market Value (US$ Mn) and Analysis By Region, 2015-2021
13.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. Asia Pacific
13.3.5. Middle East and Africa (MEA)
13.4. Market Attractiveness Analysis By Region

14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021
14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
14.4.1. By Country
14.4.1.1. U.S.
14.4.1.2. Canada
14.4.1.3. Rest of North America
14.4.2. By Device Type
14.4.3. By Product
14.4.4. By Application
14.4.5. By Grade Type
14.4.6. By Distribution Channel
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Device Type
14.5.3. By Product
14.5.4. By Application
14.5.5. By Grade Type
14.5.6. By Distribution Channel

15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021
15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
15.4.1. By Country
15.4.1.1. Brazil
15.4.1.2. Mexico
15.4.1.3. Rest of Latin America
15.4.2. By Device Type
15.4.3. By Product
15.4.4. By Application
15.4.5. By Grade Type
15.4.6. By Distribution Channel
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Device Type
15.5.3. By Product
15.5.4. By Application
15.5.5. By Grade Type
15.5.6. By Distribution Channel

16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021
16.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
16.4.1. By Country
16.4.1.1. Germany
16.4.1.2. France
16.4.1.3. U.K.
16.4.1.4. Italy
16.4.1.5. Russia
16.4.1.6. Rest of Europe
16.4.2. By Device Type
16.4.3. By Product
16.4.4. By Application
16.4.5. By Grade Type
16.4.6. By Distribution Channel
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Device Type
16.5.3. By Product
16.5.4. By Application
16.5.5. By Grade Type
16.5.6. By Distribution Channel

17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021
17.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
17.4.1. By Country
17.4.1.1. China
17.4.1.2. Japan
17.4.1.3. South Korea
17.4.1.4. Rest of Asia Pacific
17.4.2. By Device Type
17.4.3. By Product
17.4.4. By Application
17.4.5. By Grade Type
17.4.6. By Distribution Channel
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Device Type
17.5.3. By Product
17.5.4. By Application
17.5.5. By Grade Type
17.5.6. By Distribution Channel

18.1. Introduction
18.2. Pricing Analysis
18.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021
18.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
18.4.1. By Country
18.4.1.1. GCC Countries
18.4.1.2. South Africa
18.4.1.3. Turkey
18.4.1.4. Rest of Middle East and Africa
18.4.2. By Device Type
18.4.3. By Product
18.4.4. By Application
18.4.5. By Grade Type
18.4.6. By Distribution Channel
18.5. Market Attractiveness Analysis
18.5.1. By Country
18.5.2. By Device Type
18.5.3. By Product
18.5.4. By Application
18.5.5. By Grade Type
18.5.6. By Distribution Channel

19.1. Introduction
19.1.1. Market Value Proportion Analysis, By Key Countries
19.1.2. Global Vs. Country Growth Comparison
19.2. US Wearable Healthcare Devices Market Analysis
19.2.1. Value Proportion Analysis by Market Taxonomy
19.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.2.2.1. By Device Type
19.2.2.2. By Product
19.2.2.3. By Application
19.2.2.4. By Grade Type
19.2.2.5. By Distribution Channel
19.3. Canada Wearable Healthcare Devices Market Analysis
19.3.1. Value Proportion Analysis by Market Taxonomy
19.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.3.2.1. By Device Type
19.3.2.2. By Product
19.3.2.3. By Application
19.3.2.4. By Grade Type
19.3.2.5. By Distribution Channel
19.4. Mexico Wearable Healthcare Devices Market Analysis
19.4.1. Value Proportion Analysis by Market Taxonomy
19.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.4.2.1. By Device Type
19.4.2.2. By Product
19.4.2.3. By Application
19.4.2.4. By Grade Type
19.4.2.5. By Distribution Channel
19.5. Brazil Wearable Healthcare Devices Market Analysis
19.5.1. Value Proportion Analysis by Market Taxonomy
19.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.5.2.1. By Device Type
19.5.2.2. By Product
19.5.2.3. By Application
19.5.2.4. By Grade Type
19.5.2.5. By Distribution Channel
19.6. Germany Wearable Healthcare Devices Market Analysis
19.6.1. Value Proportion Analysis by Market Taxonomy
19.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.6.2.1. By Device Type
19.6.2.2. By Product
19.6.2.3. By Application
19.6.2.4. By Grade Type
19.6.2.5. By Distribution Channel
19.7. France Wearable Healthcare Devices Market Analysis
19.7.1. Value Proportion Analysis by Market Taxonomy
19.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.7.2.1. By Device Type
19.7.2.2. By Product
19.7.2.3. By Application
19.7.2.4. By Grade Type
19.7.2.5. By Distribution Channel
19.8. Italy Wearable Healthcare Devices Market Analysis
19.8.1. Value Proportion Analysis by Market Taxonomy
19.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.8.2.1. By Device Type
19.8.2.2. By Product
19.8.2.3. By Application
19.8.2.4. By Grade Type
19.8.2.5. By Distribution Channel
19.9. Russia Wearable Healthcare Devices Market Analysis
19.9.1. Value Proportion Analysis by Market Taxonomy
19.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.9.2.1. By Device Type
19.9.2.2. By Product
19.9.2.3. By Application
19.9.2.4. By Grade Type
19.9.2.5. By Distribution Channel
19.10. UK Wearable Healthcare Devices Market Analysis
19.10.1. Value Proportion Analysis by Market Taxonomy
19.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.10.2.1. By Device Type
19.10.2.2. By Product
19.10.2.3. By Application
19.10.2.4. By Grade Type
19.10.2.5. By Distribution Channel
19.11. China Wearable Healthcare Devices Market Analysis
19.11.1. Value Proportion Analysis by Market Taxonomy
19.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.11.2.1. By Device Type
19.11.2.2. By Product
19.11.2.3. By Application
19.11.2.4. By Grade Type
19.11.2.5. By Distribution Channel
19.12. Japan Wearable Healthcare Devices Market Analysis
19.12.1. Value Proportion Analysis by Market Taxonomy
19.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.12.2.1. By Device Type
19.12.2.2. By Product
19.12.2.3. By Application
19.12.2.4. By Grade Type
19.12.2.5. By Distribution Channel
19.13. South Korea Wearable Healthcare Devices Market Analysis
19.13.1. Value Proportion Analysis by Market Taxonomy
19.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.13.2.1. By Device Type
19.13.2.2. By Product
19.13.2.3. By Application
19.13.2.4. By Grade Type
19.13.2.5. By Distribution Channel
19.14. GCC Countries Wearable Healthcare Devices Market Analysis
19.14.1. Value Proportion Analysis by Market Taxonomy
19.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.14.2.1. By Device Type
19.14.2.2. By Product
19.14.2.3. By Application
19.14.2.4. By Grade Type
19.14.2.5. By Distribution Channel
19.15. South Africa Wearable Healthcare Devices Market Analysis
19.15.1. Value Proportion Analysis by Market Taxonomy
19.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.15.2.1. By Device Type
19.15.2.2. By Product
19.15.2.3. By Application
19.15.2.4. By Grade Type
19.15.2.5. By Distribution Channel
19.16. Turkey Wearable Healthcare Devices Market Analysis
19.16.1. Value Proportion Analysis by Market Taxonomy
19.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.16.2.1. By Device Type
19.16.2.2. By Product
19.16.2.3. By Application
19.16.2.4. By Grade Type
19.16.2.5. By Distribution Channel
19.16.3. Competition Landscape and Player Concentration in the Country

20.1. Market Analysis by Tier of Companies
20.2. Market Concentration
20.3. Market Share Analysis of Top Players
20.4. Market Presence Analysis
20.4.1. By Regional footprint of Players
20.4.2. Product footprint by Players

21.1. Competition Dashboard
21.2. Competition Benchmarking
21.3. Competition Deep Dive
21.3.1. Apple Inc. (US)
21.3.1.1. Overview
21.3.1.2. Product Portfolio
21.3.1.3. Sales Footprint
21.3.1.4. Strategy Overview
21.3.2. Koninklijke Philips N.V. (Netherlands)
21.3.2.1. Overview
21.3.2.2. Product Portfolio
21.3.2.3. Sales Footprint
21.3.2.4. Strategy Overview
21.3.3. Fitbit Inc. (US)
21.3.3.1. Overview
21.3.3.2. Product Portfolio
21.3.3.3. Sales Footprint
21.3.3.4. Strategy Overview
21.3.4. OMRON Corporation (Japan)
21.3.4.1. Overview
21.3.4.2. Product Portfolio
21.3.4.3. Sales Footprint
21.3.4.4. Strategy Overview
21.3.5. Medtronic PLC (Ireland)
21.3.5.1. Overview
21.3.5.2. Product Portfolio
21.3.5.3. Sales Footprint
21.3.5.4. Strategy Overview
21.3.6. GE Healthcare (US)
21.3.6.1. Overview
21.3.6.2. Product Portfolio
21.3.6.3. Sales Footprint
21.3.6.4. Strategy Overview
21.3.7. Abbott Laboratories (US)
21.3.7.1. Overview
21.3.7.2. Product Portfolio
21.3.7.3. Sales Footprint
21.3.7.4. Strategy Overview
21.3.8. Garmin Ltd. (US)
21.3.8.1. Overview
21.3.8.2. Product Portfolio
21.3.8.3. Sales Footprint
21.3.8.4. Strategy Overview
21.3.9. Dexcom Inc. (US)
21.3.9.1. Overview
21.3.9.2. Product Portfolio
21.3.9.3. Sales Footprint
21.3.9.4. Strategy Overview
21.3.10. Masimo Corporation (US)
21.3.10.1. Overview
21.3.10.2. Product Portfolio
21.3.10.3. Sales Footprint
21.3.10.4. Strategy Overview